methylprednisolone has been researched along with natriuretic peptide, brain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bech, JN; Lauridsen, TG; Nielsen, S; Pedersen, EB; Vase, H | 1 |
| Pan, X; Yu, X; Zhang, J; Zhao, G | 1 |
| Andrews, J; Bissell, LA; Buch, MH; Burska, AN; Conaghan, PG; Donica, H; Emery, P; Hensor, EM; Keen, H; Kozera, L; Mackie, SL; Morgan, AW; Nam, JL; Villeneuve, E | 1 |
| Chen, Z; Chu, H; Liu, Y; Ma, X | 1 |
| Bednarczuk, T; Glowczynska, R; Milczarek-Banach, J; Miskiewicz, P; Opolski, G | 1 |
4 trial(s) available for methylprednisolone and natriuretic peptide, brain
| Article | Year |
|---|---|
Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Epithelial Sodium Channels; Female; Humans; Kidney; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Pulse; Renin; Sodium | 2010 |
Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Aminophylline; Bronchodilator Agents; Disease Progression; Drug Combinations; Female; Furosemide; Glucocorticoids; Health Status; Health Status Indicators; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Pulmonary Disease, Chronic Obstructive; Quality of Life; Vasodilator Agents | 2012 |
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.
Topics: Adult; Aftercare; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Diabetes Complications; Double-Blind Method; Early Diagnosis; Female; Glucocorticoids; Humans; Infliximab; Insulin; Insulin Resistance; Lipid Metabolism; Male; Methotrexate; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Risk Factors; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2016 |
Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves' Orbitopathy.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulse Therapy, Drug; Severity of Illness Index | 2018 |
1 other study(ies) available for methylprednisolone and natriuretic peptide, brain
| Article | Year |
|---|---|
Acute exacerbation of idiopathic pulmonary fibrosis after total hip replacement.
Topics: Aged; Anesthesia, Spinal; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Blood Gas Monitoring, Transcutaneous; Disease Progression; Dyspnea; Echocardiography; Fatal Outcome; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Male; Methylprednisolone; Natriuretic Peptide, Brain; Oxygen Inhalation Therapy; Perioperative Care; Respiration, Artificial; Tomography, X-Ray Computed | 2016 |